GSK2136525

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GSK2136525, covering 2017-06-08 to 2017-06-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Pharmacodynamics and Pharmacokinetics of GSK2136525 Repeat Dose in Rheumatoid Arthritis [Phase 1]